Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 696 - CONTROL OF TUBERCULOSIS CODE › Subpart B - TUBERCULOSIS PREVENTION AND CONTROL MEASURES › Section 696.140 - Screening for Latent Tuberculosis Infection (LTBI) and Active Tuberculosis (TB) Disease

Current through Register Vol. 48, No. 28, July 12, 2024
A TB screening test shall be used when screening persons for
				  latent TB infection (LTBI). Persons who have signs and symptoms of active TB
				  disease or a positive TB screening test result shall complete a diagnostic
				  evaluation for active TB disease in accordance with the Centers for Disease
				  Control and Prevention (CDC) guidelines, Targeted Tuberculin Testing and
				  Treatment of Latent Tuberculosis Infection and Guidelines for Health-Care
				  Settings.
a) Screening for Latent TB
				Infection
1) Persons who are contacts to
				suspected or confirmed cases of active TB disease shall be evaluated in
				accordance with the CDC Guidelines for the Investigation of Contacts.
2) Workers and clients at health care
				settings and other residential settings serving high-risk groups shall be
				screened in accordance with this subsection (a)(2) and the following CDC
				guidelines: Targeted Tuberculin Testing and Treatment of Latent Tuberculosis
				Infection, Guidelines for Health-Care Settings, Prevention and Control of
				Tuberculosis in Correctional and Detention Facilities: Recommendations from
				CDC.
A) Health care workers and workers in
				other residential care settings serving high-risk groups shall obtain a TB
				screening test within seven days after being employed. If Mantoux skin testing
				is used, two-step testing shall be done, with the first test placed within
				seven days after employment. However, a second skin test is not needed if the
				worker has a documented skin test result from any time during the previous 12
				months. The need for routine periodic screening shall be determined by a risk
				assessment.
B) All clients in
				non-acute care residential health care settings serving high-risk groups shall
				obtain a TB screening test within seven days after admission. If Mantoux skin
				testing is used for clients with an anticipated stay longer than 30 days,
				two-step testing shall be done, with the first test placed within seven days
				after admission. Routine periodic screening shall be determined by a risk
				assessment performed in cooperation with the local TB control
				authority.
C) TB screening shall be
				instituted in other residential care settings serving high-risk groups as
				directed by the local TB control authority or the Department when a community
				or residential care setting has a higher than expected incidence of active TB
				disease or prevalence of LTBI.
D)
				Inmates and employees in correctional and detention facilities shall be
				screened in accordance with the CDC guideline Prevention and Control of
				Tuberculosis in Correctional and Detention Facilities: Recommendations from
				CDC.
3) Workers in child
				day care and pre-school settings shall obtain a TB screening test within seven
				days after being employed. If Mantoux skin testing is used, two-step testing
				shall be done, with the first test administered within seven days after
				employment. Routine, periodic screening of workers shall be determined by the
				child day care or pre-school facility's TB risk assessment.